# Sharps Technology signs deal to acquire Nephron's InjectEZ syringe plant for $50M

Sharps Technology signed an asset purchase agreement to acquire Nephron Pharmaceuticals' InjectEZ specialty syringe manufacturing facility for $50 million, backed by a term sheet for up to $75 million in debt financing.

- Type: Acquisition
- Announced: 2023-09-26
- Where: West Columbia, South Carolina, United States
- Value: $50.0M
- Status: announced
- Products: copolymer prefillable syringes, syringe systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md), [Plastics and Polymers](https://endata.com/sectors/plastics-polymers.md)

## Companies

- [Sharps Technology](https://endata.com/companies/11050.md) (acquirer)
- [Nephron Pharmaceuticals](https://endata.com/companies/11051.md) (target)

## Sources

- [globenewswire.com](https://www.globenewswire.com/news-release/2023/09/26/2749524/0/en/Sharps-Technology-Signs-Asset-Purchase-Agreement-to-Acquire-InjectEZ-Specialty-Copolymer-Syringe-Manufacturing-Facility-and-a-10-Year-Purchase-Agreement-for-Over-400-Million-from-N.html), 2023-09-26: "$50 Million acquisition of InjectEZ strengthens manufacturing capacity and establishes Sharps' leading position in the specialized copolymer prefillable syringe system industry"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.